Browsing by Author "Cruz A."

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    International European respiratory society/American thoracic society guidelines on severe asthma
    (European Respiratory Society, 2014) Bousquet J.; Khaltaev N.; Cruz A.; Yorgancioglu A.; Chuchalin A.
    [No abstract available]
  • No Thumbnail Available
    Item
    Aria 2016 executive summary: Integrated care pathways for predictive medicine across the life cycle; [ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıp uygulamaları için bütünleştirilmiş yaklaşım yolakları]
    (Ankara University, 2017) Yorgancioğlu A.A.; Kalayci Ö.; Cingi C.; Gemicioğlu B.; Kalyoncu A.F.; Agache I.; Bachert C.; Bedbrook A.; Canonica G.W.; Casale T.; Cruz A.; Fokkens W.E.; Hellings P.; Samolinski B.; Bousquet J.
    The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA-disseminated and implemented in over 70 countries globally- is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK (MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multidisciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease. © 2017, Ankara University. All rights reserved.
  • No Thumbnail Available
    Item
    Helsinki by nature: The Nature Step to Respiratory Health
    (BioMed Central Ltd., 2019) Haahtela T.; Von Hertzen L.; Anto J.M.; Bai C.; Baigenzhin A.; Bateman E.D.; Behera D.; Bennoor K.; Camargos P.; Chavannes N.; De Sousa J.C.; Cruz A.; Do Céu Teixeira M.; Erhola M.; Furman E.; Gemicioǧlu B.; Gonzalez Diaz S.; Hellings P.W.; Jousilahti P.; Khaltaev N.; Kolek V.; Kuna P.; La Grutta S.; Lan L.T.T.; Maglakelidze T.; Masjedi M.R.; Mihaltan F.; Mohammad Y.; Nunes E.; Nyberg A.; Quel J.; Rosado-Pinto J.; Sagara H.; Samolinski B.; Schraufnagel D.; Sooronbaev T.; Tag Eldin M.; To T.; Valiulis A.; Varghese C.; Vasankari T.; Viegi G.; Winders T.; Yañez A.; Yorgancioǧlu A.; Yusuf O.; Bousquet J.; Billo N.E.
    Background: The Nature Step to Respiratory Health was the overarching theme of the 12th General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) in Helsinki, August 2018. New approaches are needed to improve respiratory health and reduce premature mortality of chronic diseases by 30% till 2030 (UN Sustainable Development Goals, SDGs). Planetary health is defined as the health of human civilization and the state of the natural systems on which it depends. Planetary health and human health are interconnected, and both need to be considered by individuals and governments while addressing several SDGs. Results: The concept of the Nature Step has evolved from innovative research indicating, how changed lifestyle in urban surroundings reduces contact with biodiverse environments, impoverishes microbiota, affects immune regulation and increases risk of NCDs. The Nature Step calls for strengthening connections to nature. Physical activity in natural environments should be promoted, use of fresh vegetables, fruits and water increased, and consumption of sugary drinks, tobacco and alcohol restricted. Nature relatedness should be part of everyday life and especially emphasized in the care of children and the elderly. Taking "nature" to modern cities in a controlled way is possible but a challenge for urban planning, nature conservation, housing, traffic arrangements, energy production, and importantly for supplying and distributing food. Actions against the well-known respiratory risk factors, air pollution and smoking, should be taken simultaneously. Conclusions: In Finland and elsewhere in Europe, successful programmes have been implemented to reduce the burden of respiratory disorders and other NCDs. Unhealthy behaviour can be changed by well-coordinated actions involving all stakeholders. The growing public health concern caused by NCDs in urban surroundings cannot be solved by health care alone; a multidisciplinary approach is mandatory. © 2019 The Author(s).
  • No Thumbnail Available
    Item
    A global respiratory perspective on the COVID-19 pandemic: Commentary and action proposals
    (European Respiratory Society, 2020) To T.; Viegi G.; Cruz A.; Taborda-Barata L.; Asher I.; Behera D.; Bennoor K.; Boulet L.-P.; Bousquet J.; Camargos P.; Conceiçao C.; Diaz S.G.; El-Sony A.; Erhola M.; Gaga M.; Halpin D.; Harding L.; Maghlakelidze T.; Masjedi M.R.; Mohammad Y.; Nunes E.; Pigearias B.; Sooronbaev T.; Stelmach R.; Tsiligianni I.; Lan L.T.T.; Valiulis A.; Wang C.; Williams S.; Yorgancioglu A.
    [No abstract available]
  • No Thumbnail Available
    Item
    Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
    (John Wiley and Sons Inc, 2023) Bousquet J.; Shamji M.H.; Anto J.M.; Schünemann H.J.; Canonica G.W.; Jutel M.; Del Giacco S.; Zuberbier T.; Pfaar O.; Fonseca J.A.; Sousa-Pinto B.; Klimek L.; Czarlewski W.; Bedbrook A.; Amaral R.; Ansotegui I.J.; Bosnic-Anticevich S.; Braido F.; Chaves Loureiro C.; Gemicioglu B.; Haahtela T.; Kulus M.; Kuna P.; Kupczyk M.; Matricardi P.; Regateiro F.S.; Samolinski B.; Sofiev M.; Toppila-Salmi S.; Valiulis A.; Ventura M.T.; Barbara C.; Bergmann K.C.; Bewick M.; Blain H.; Bonini M.; Boulet L.-P.; Bourret R.; Brusselle G.; Brussino L.; Buhl R.; Cardona V.; Casale T.; Cecchi L.; Charpin D.; Cherrez-Ojeda I.; Chu D.K.; Cingi C.; Costa E.M.; Cruz A.; Devillier P.; Dramburg S.; Fokkens W.; Gotua M.; Heffler E.; Ispayeva Z.; Ivancevich J.C.; Joos G.; Kaidashev I.; Kraxner H.; Kvedariene V.; Larenas-Linnemann D.E.; Laune D.; Lourenço O.; Louis R.; Makela M.; Makris M.; Maurer M.; Melén E.; Micheli Y.; Morais-Almeida M.; Mullol J.; Niedoszytko M.; O'Hehir R.; Okamoto Y.; Olze H.; Papadopoulos N.G.; Papi A.; Patella V.; Pétré B.; Pham-Thi N.; Puggioni F.; Quirce S.; Roche N.; Rouadi P.; Sá-Sousa A.; Sagara H.; Sastre J.; Scichilone N.; Sheikh A.; Sova M.; Suppli Ulrik C.; Taborda-Barata L.; Todo-Bom A.; Torres M.; Tsiligianni I.; Usmani O.S.; Valovirta E.; Vasankari T.; Vieira R.J.; Wallace D.; Waserman S.; Zidarn M.; Yorgancioglu A.; Zhang L.; Chivato T.; Ollert M.
    Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient-reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real-life studies and allergen challenges. Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real-life, it secondly proposed quality-of-life digital biomarkers including daily EQ-5D visual analogue scales and the bi-weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed. © 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.